A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Insmed Inc stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 114,651 shares of INSM stock, worth $8.29 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
114,651
Previous 146,912 21.96%
Holding current value
$8.29 Million
Previous $3.99 Million 92.75%
% of portfolio
0.41%
Previous 0.22%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$22.0 - $69.71 $709,742 - $2.25 Million
-32,261 Reduced 21.96%
114,651 $7.68 Million
Q1 2024

Apr 17, 2024

BUY
$25.72 - $29.94 $228,316 - $265,777
8,877 Added 6.43%
146,912 $3.99 Million
Q4 2023

Jan 10, 2024

SELL
$23.42 - $31.74 $772,180 - $1.05 Million
-32,971 Reduced 19.28%
138,035 $4.28 Million
Q3 2023

Oct 27, 2023

BUY
$19.86 - $26.93 $285,566 - $387,226
14,379 Added 9.18%
171,006 $4.32 Million
Q2 2023

Aug 09, 2023

BUY
$16.44 - $21.1 $324,525 - $416,514
19,740 Added 14.42%
156,627 $3.31 Million
Q1 2023

Apr 20, 2023

BUY
$16.26 - $21.73 $120,421 - $160,932
7,406 Added 5.72%
136,887 $2.33 Million
Q4 2022

Jan 12, 2023

SELL
$16.98 - $23.15 $434,399 - $592,246
-25,583 Reduced 16.5%
129,481 $2.59 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $399,100 - $539,205
19,114 Added 14.06%
155,064 $3.34 Million
Q2 2022

Jul 19, 2022

SELL
$17.07 - $25.71 $949,638 - $1.43 Million
-55,632 Reduced 29.04%
135,950 $2.68 Million
Q1 2022

Apr 26, 2022

BUY
$20.42 - $28.13 $192,131 - $264,675
9,409 Added 5.16%
191,582 $4.5 Million
Q4 2021

Feb 14, 2022

SELL
$25.89 - $33.45 $929,684 - $1.2 Million
-35,909 Reduced 16.47%
182,173 $4.96 Million
Q3 2021

Nov 12, 2021

SELL
$22.46 - $29.47 $338,270 - $443,847
-15,061 Reduced 6.46%
218,082 $6.01 Million
Q2 2021

Aug 13, 2021

BUY
$24.17 - $36.01 $373,378 - $556,282
15,448 Added 7.1%
233,143 $6.64 Million
Q1 2021

May 17, 2021

BUY
$32.28 - $44.3 $7.03 Million - $9.64 Million
217,695 New
217,695 $7.42 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.79B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Hennion & Walsh Asset Management, Inc. Portfolio

Follow Hennion & Walsh Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.